The DOI matches its Crossref record; 294 of the 294 references it cites were found in a registry or an index.
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
Open accessAbstract
Cardiovascular disease is the leading cause of mortality in uremic patients. In large cross-sectional studies of dialysis patients, traditional cardiovascular risk factors such as hypertension and hypercholesterolemia have been found to have low predictive power, while markers of inflammation and malnutrition are highly correlated with cardiovascular mortality. However, the pathophysiology of the disease process that links uremia, inflammation, and malnutrition with increased cardiovascular complications is not well understood. We hereby propose the hypothesis that increased oxidative stress and its sequalae is a major contributor to increased atherosclerosis and cardiovascular morbidity and mortality found in uremia. This hypothesis is based on studies that conclusively demonstrate an increased oxidative burden in uremic patients, before and particularly after renal replacement therapies, as evidenced by higher concentrations of multiple biomarkers of oxidative stress. This hypothesis also provides a framework to explain the link that activated phagocytes provide between oxidative stress and inflammation (from infectious and non-infections causes) and the synergistic role that malnutrition (as reflected by low concentrations of albumin and/or antioxidants) contributes to the increased burden of cardiovascular disease in uremia. We further propose that retained uremic solutes such as beta-2 microglobulin, advanced glycosylated end products (AGE), cysteine, and homocysteine, which are substrates for oxidative injury, further contribute to the pro-atherogenic milieu of uremia. Dialytic therapy, which acts to reduce the concentration of oxidized substrates, improves the redox balance. However, processes related to dialytic therapy, such as the prolonged use of catheters for vascular access and the use of bioincompatible dialysis membranes, can contribute to a pro-inflammatory and pro-oxidative state and thus to a pro-atherogenic state. Anti-oxidative therapeutic strategies for patients with uremia are in their very early stages; nonetheless, early studies demonstrate the potential for significant efficacy in reducing cardiovascular complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The uncoupling of endothelial nitric oxide synthase (eNOS), oxidative stress mechanism is involved in uremia, a condition when the kidney does not work properly and waste products instead of urine are excreted into the bloodstream (Himmelfarb et al. 2002).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Himmelfarb et al. 2002
Citations
Cites
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
Schafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587
Clinical epidemiology of cardiovascular disease in chronic renal disease
Rn, F., Parfrey, P. S., & Sarnak, M. J. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,960
Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., & Striker, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301301 · Cited by 2,328
Dietary Protein Intake and the Progressive Nature of Kidney Disease:
Epstein, F. H., Brenner, B. M., Meyer, T. W., & Hostetter, T. H. (1982) · New England Journal of Medicine · doi:10.1056/nejm198209093071104 · Cited by 2,067
Advanced oxidation protein products as a novel marker of oxidative stress in uremia
Witko‐Sarsat, V., Friedlander, M. A., Capeillère‐Blandin, C., Nguyen‐Khoa, T., Nguyen, A., Zingraff, J., Jungers, P., & Descamps‐Latscha, B. (1996) · Kidney International · doi:10.1038/ki.1996.186 · Cited by 2,000
Lowrie, E. G., & Lew, N. L. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70364-5 · Cited by 1,965
Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,898
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
Stenvinkel, P., Heimbürger, O., Paultre, F., Diczfalusy, U., Wang, T., Berglund, L., & Jogestrand, T. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00422.x · Cited by 1,767
Self-citation
Research works printed but not linked: 1
- Bloembergen, 1995, The relationship of dialysis membrane and cause-specific mortality in chronic hemodialysis patients, J Am Soc Nephrol, 6, 521
Cited by
Sorted by citations
Items 301–400 of 1,000
Ma, N., Wei, Z., Hu, J., Gu, W., & Ci, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.768700 · Cited by 59
Nakayama, M., Sato, T., Miyazaki, M., Matsushima, M., Sato, H., Taguma, Y., & Ito, S. (2011) · Hypertension Research · doi:10.1038/hr.2011.96 · Cited by 59
DNA Damage in Chronic Kidney Disease: Evaluation of Clinical Biomarkers
Schupp, N., Stopper, H., & Heidland, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3592042 · Cited by 59
Dai, L., Watanabe, M., Qureshi, A. R., Mukai, H., Machowska, A., Heimbürger, O., Barany, P. F., Lindholm, B., & Stenvinkel, P. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.07.035 · Cited by 59
Self-citationFortuño, A., Beloqui, Ó., José, G. S., Moreno, M. U., Zalba, G., & Dı́ez, J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09913.x · Cited by 59
Winkelmayer, W. C., Charytan, D. M., Levin, R., & Avorn, J. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.009 · Cited by 59
Statins in the management of dyslipidemia associated with chronic kidney disease
Epstein, M., & Vaziri, N. D. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.33 · Cited by 58
Shao, B., de Boer, I. H., Tang, C., Mayer, P. S., Zelnick, L. R., Afkarian, M., Heinecke, J. W., & Himmelfarb, J. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00060 · Cited by 57
Self-citationEffects of Hemodialysis, Dialyser Type and Iron Infusion on Oxidative Stress in Uremic Patients
Müller, C., Eisenbrand, G., Gradinger, M., Rath, T., Albert, F. W., Vienken, J., Singh, R., Farmer, P. B., Stockis, J., & Janzowski, C. (2004) · Free Radical Research · doi:10.1080/10715760400011452 · Cited by 58
Capillary electrophoresis in the evaluation of aminothiols in body fluids
Carlucci, F., & Tabucchi, A. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.07.030 · Cited by 57
Periodontitis Predicts Elevated C-reactive Protein Levels in Chronic Kidney Disease
Ioannidou, E., Swede, H., & Dongari‐Bagtzoglou, A. I. (2011) · Journal of Dental Research · doi:10.1177/0022034511423394 · Cited by 57
Fellstr�m, B. C., Jardine, A. G., Soveri, I., Cole, E., nhagen-Riska, C. G., Neumayer, H. H., Maes, B., Gimpelewicz, C. R., & Holdaas, H. (2005) · Transplantation · doi:10.1097/01.tp.0000160764.35083.b8 · Cited by 57
Witasp, A., Carrero, J. J., Heimbürger, O., Lindholm, B., Hammarqvist, F., Stenvinkel, P., & Nordfors, L. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02293.x · Cited by 56
Self-citationUNRESOLVED ISSUES IN DIALYSIS: Managing Erythropoietin Hyporesponsiveness
Kwack, C., & Balakrishnan, V. S. (2006) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2006.00141.x · Cited by 56
Diffusive Silicon Nanopore Membranes for Hemodialysis Applications
Kim, S. B., Feinberg, B. J., Kant, R., Chui, B. W., Goldman, K., Park, J., Moses, W., Blaha, C., Iqbal, Z., Chow, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159526 · Cited by 55
Kamgar, M. K., Zaldivar, F. P., Vaziri, N. D., & Pahl, M. V. (2009) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30881-6 · Cited by 56
Valli, A., Suliman, M. E., Meert, N., Vanholder, R. C., Lindholm, B., Stenvinkel, P., Watanabe, M., Barany, P. F., Alvestrand, A., & Anderstam, B. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.12.026 · Cited by 55
Self-citationChen, S., Umamaheswari, R., Govindasamy, M., Chen, T.-W., Ali, M. A., Al-Hemaid, F. M. A., Elshikh, M. S., & Farah, M. A. (2018) · Inorganic Chemistry Frontiers · doi:10.1039/c7qi00799j · Cited by 54
Phan, O., Ivanovski, O., Nikolov, I. G., Joki, N., Maizel, J., Louvet, L., Chasseraud, M., Nguyen‐Khoa, T., Lacour, B., Drüeke, T. B., et al. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm699 · Cited by 54
Misdistribution of iron and oxidative stress in chronic kidney disease
Nakanishi, T., Kuragano, T., Nanami, M., Nagasawa, Y., & Hasuike, Y. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.025 · Cited by 57
Leehey, D. J., Kramer, H., Daoud, T. M., Chatha, M. P., & Isreb, M. A. (2005) · BMC Nephrology · doi:10.1186/1471-2369-6-8 · Cited by 54
Mandal, A. K., Woodi, M., Sood, V., Krishnaswamy, P. R., Rao, A., Ballal, S. H., & Balaram, P. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.05.006 · Cited by 54
Stenvinkel, P., Lindholm, B., & Heimbürger, O. (2004) · Seminars in Dialysis · doi:10.1111/j.0894-0959.2004.17611.x · Cited by 54
Self-citationPelletier, C. C., Koppe, L., Croze, M. L., Kalbacher, E., Vella, R., Guebre‐Egziabher, F., Géloën, A., Badet, L., Fouque, D. P., & Soulage, C. O. (2013) · Kidney International · doi:10.1038/ki.2013.9 · Cited by 53
Inflammation and cardiovascular events in individuals with and without chronic kidney disease
Weiner, D. E., Tighiouart, H., Elsayed, E. F., Griffith, J. L., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2008) · Kidney International · doi:10.1038/ki.2008.75 · Cited by 53
Zhang, Z., Yang, T., Li, Y., Li, J., Yang, Q., Wang, L., Jiang, L., & Su, B. (2022) · Membranes · doi:10.3390/membranes12030253 · Cited by 52
Panichi, V., Rosati, A., Paoletti, S., Ferrandello, P. F., MIGLIORI, M., Beati, S., Bernabini, G., Daini, R., Casani, A., Angelini, D., et al. (2011) · Blood Purification · doi:10.1159/000321369 · Cited by 52
Bro, S., Flyvbjerg, A., Binder, C. J., Bang, C. A., Denner, L. A., Ølgaard, K., & Nielsen, L. B. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.01.015 · Cited by 52
Targeting Reactive Oxygen Species in Hypertension
Delles, C., Miller, W. H., & Dominiczak, A. F. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.2008 · Cited by 51
The kidney disease wasting: Inflammation, oxidative stress, and diet‐gene interaction
Kalantar‐Zadeh, K., & Balakrishnan, V. S. (2006) · Hemodialysis International · doi:10.1111/j.1542-4758.2006.00124.x · Cited by 52
An Oral Adsorbent, AST-120, Suppresses Oxidative Stress in Uremic Rats
Nakagawa, N., Hasebe, N., Sumitomo, K., Fujino, T., Fukuzawa, J., Hirayama, T., & Kikuchi, K. (2006) · American Journal of Nephrology · doi:10.1159/000096423 · Cited by 51
Circulating Bacterial Fragments as Cardiovascular Risk Factors in CKD
Szeto, C., McIntyre, C. W., & Li, P. K. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018010068 · Cited by 51
Nonoxidized, Biologically Active Parathyroid Hormone Determines Mortality in Hemodialysis Patients
Tepel, M., Armbruster, F. P., Grön, H. J., Scholze, A., Reichetzeder, C., Roth, H. J., & Hocher, B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2139 · Cited by 51
Liu, J., Tian, J., Chaudhry, M. A., Maxwell, K., Yan, Y., Wang, X., Shah, P. T., Khawaja, A. A., Martin, R., Robinette, T. J., et al. (2017) · Scientific Reports · doi:10.1038/srep46893 · Cited by 51
Protein Oxidative Stress and Dyslipidemia in Dialysis Patients
de Mattos, A. M., Marino, L. V., Ovídio, P. P., Jordão, A. A., de Almeida, C. C. S., & Chiarello, P. G. (2011) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2011.01009.x · Cited by 50
Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients
Schupp, N., Dette, E. M., Schmid, U., Bahner, U., Winkler, M., Heidland, A., & Stopper, H. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0310-y · Cited by 50
Biological Effects of Electrolyzed Water in Hemodialysis
Nakayama, M., Kabayama, S., Nakano, H., Zhu, W.-J., Terawaki, H., Nakayama, K., Katoh, K., Satoh, T., & Ito, S. (2009) · Nephron Clinical Practice · doi:10.1159/000210569 · Cited by 50
Khazim, K., Giustarini, D., Rossi, R., Verkaik, D., Cornell, J. E., Cunningham, S. E. D., Mohammad, M. S., Trochta, K., Lorenzo, C., Folli, F. B., et al. (2013) · Translational research · doi:10.1016/j.trsl.2012.12.014 · Cited by 50
Reverse Cholesterol Transport Pathway in Experimental Chronic Renal Failure
Moradi, H., Yuan, J. J., Ni, Z., Norris, K. C., & Vaziri, N. D. (2009) · American Journal of Nephrology · doi:10.1159/000210020 · Cited by 50
Nakayama, M., Itami, N., Suzuki, H., Hamada, H., Yamamoto, R., Tsunoda, K., Osaka, N., Nakano, H., Maruyama, Y., Kabayama, S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18537-x · Cited by 50
Metabolic syndrome severity score and the progression of CKD
Wu, M., Shu, Y., Wang, L., Song, L., Chen, S., Liu, Y., Bi, J., Li, D., Yang, Y., Hu, Y., et al. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13646 · Cited by 50
Athyros, V. G., Katsiki, N., Karagiannis, A. I., & Mikhailidis, D. P. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1053464 · Cited by 48
HSP27 and HSP70 serum and urine levels in patients suffering from chronic kidney disease
Lebherz-Eichinger, D., Ankersmit, H. J., Hacker, S., Hetz, H., Kimberger, O., Schmidt, E. M., Reiter, T., Hörl, W. H., Haas, M., Krenn, C. G., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.10.010 · Cited by 49
Evidence-Based Cardiology in Hemodialysis Patients
Allon, M. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060632 · Cited by 52
Targeting Na/K-ATPase Signaling: A New Approach to Control Oxidative Stress
Liu, J., Lilly, M. N., & Shapiro, J. I. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666180110101052 · Cited by 49
Noce, A., Marrone, G., Urciuoli, S., Daniele, F. D., Lauro, M. D., Zaitseva, A. P., Daniele, N. D., & Romani, A. (2021) · Nutrients · doi:10.3390/nu13020581 · Cited by 52
Impact of Residual Renal Function on Volume Status in Chronic Renal Failure
Pecoits‐Filho, R., Gonçalves, S., Barberato, S. H., Bignelli, A. T., Lindholm, B., RIELLA, M. C., & Stenvinkel, P. (2004) · Blood Purification · doi:10.1159/000078699 · Cited by 49
Self-citationCognitive Profile of Chronic Kidney Disease and Hemodialysis Patients without Dementia
Post, J. B., Jegede, A. B., Morin, K. G., Spungen, A. M., Langhoff, E., & Sano, M. C. (2010) · Nephron Clinical Practice · doi:10.1159/000317206 · Cited by 48
Oxidative Dna Damage and Mortality in Hemodialysis and Peritoneal Dialysis Patients
Xu, H., Watanabe, M., Qureshi, A. R., Heimbürger, O., Barany, P. F., Anderstam, B., Eriksson, M., Stenvinkel, P., & Lindholm, B. (2014) · Peritoneal Dialysis International · doi:10.3747/pdi.2013.00259 · Cited by 49
Self-citationCoronary Microvascular Function in Early Chronic Kidney Disease
Charytan, D. M., Shelbert, H. R., & Carli, M. F. D. (2010) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.110.957761 · Cited by 49
Pawlak, K., Pawlak, D., & Myśliwiec, M. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.01.020 · Cited by 48
Kidney insufficiency and nutrient-based modulation of inflammation
Kalantar‐Zadeh, K., Stenvinkel, P., Bross, R., Khawar, O. S., Rammohan, M., Colman, S., & Benner, D. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000172578.56396.9e · Cited by 48
Self-citationSlowing the Progression of Vascular Calcification in Hemodialysis
Chertow, G. M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000081666.10967.05 · Cited by 48
Cardiovascular disease in chronic kidney disease: risk factors, pathogenesis, and prevention.
Ardhanari, S., Alpert, M., & Aggarwal, K. B. (2014) · PubMed · Cited by 47
Balloon-Assisted Maturation (BAM) of the Arteriovenous Fistula: The Good, the Bad, and the Ugly
Roy‐Chaudhury, P., Lee, T. C., Woodle, B., Wadehra, D. B., Campos‐Naciff, B., & MUNDA, R. T. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.10.007 · Cited by 47
Vitetta, L., Linnane, A. W., & Gobe, G. C. (2013) · Toxins · doi:10.3390/toxins5112042 · Cited by 47
Pai, A. B., & Garba (2012) · Journal of Blood Medicine · doi:10.2147/jbm.s29204 · Cited by 47
Shah, N., & Dumler, F. (2008) · International Journal of Medical Sciences · doi:10.7150/ijms.5.366 · Cited by 47
Higher Physical Activity Is Associated With Less Fatigue and Insomnia Among Patients on Hemodialysis
Sheshadri, A., Kittiskulnam, P., & Johansen, K. L. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.10.014 · Cited by 47
Eduok, U. M., Abdelrasoul, A., SHOKER, A. S., & Doan, H. D. (2021) · Materials Today Communications · doi:10.1016/j.mtcomm.2021.102183 · Cited by 53
Vascular Effects of Exercise Training in CKD
Craenenbroeck, A. H. V., Craenenbroeck, E. M. V., Kouidi, E. J., Vrints, C. J., Couttenye, M. M., & Conraads, V. M. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.13031213 · Cited by 47
Seiler-Mußler, S., Limbach, A.-S., Emrich, I. E., Pickering, J. W., Roth, H. J., Fliser, D., & Heine, G. H. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06620617 · Cited by 46
Effect of Exercise on Cardiac Tissue Oxidative and Inflammatory Mediators in Chronic Kidney Disease
Bai, Y., Sigala, W., Adams, G. R., & Vaziri, N. D. (2008) · American Journal of Nephrology · doi:10.1159/000156715 · Cited by 47
Pai, A. B., Conner, T. A., McQuade, C. R., Olp, J., & Hicks, P. (2011) · BioMetals · doi:10.1007/s10534-011-9409-6 · Cited by 46
Dietary Metabolites and Chronic Kidney Disease
Hasegawa, S., Jao, T., & Inagi, R. (2017) · Nutrients · doi:10.3390/nu9040358 · Cited by 47
Atherosclerosis and uremic retention solutes
Hörl, W. H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00944.x · Cited by 46
Joki, N., Hase, H., Tanaka, Y., Takahashi, Y., Saijyo, T., Ishikawa, H., Inishi, Y., Imamura, Y., Hara, H., Tsunoda, T., et al. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl037 · Cited by 46
End stage renal disease as a modifier of the periodontal microbiome
Araújo, M. V. F., Hong, B., Fava, P., Khan, S., Burleson, J. A., Fares, G., Samson, W., Strausbaugh, L. D., Diaz, P. I., & Ioannidou, E. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0081-x · Cited by 44
Hung, A. M., Roumie, C. L., Greevy, R. A., Liu, X., Grijalva, C. G., Murff, H. J., & Griffin, M. R. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3432 · Cited by 46
Neri, L., Rey, L. A. R., Lentine, K. L., Hinyard, L., Pinsky, B. W., Xiao, H., Dukes, J. L., & Schnitzler, M. A. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.04.025 · Cited by 45
Wang, Y.-C., Lee, W., Liao, S., Lee, L.-C., Su, Y.-J., Lee, C., & Chen, J. (2010) · Journal of Nephrology · doi:10.5301/jn.2010.5816 · Cited by 45
C-reactive Protein Is a Strong Predictor of Mortality in Hemodialysis Patients
Rački, S., Zaputović, L., Mavrić, Ž., Vujičić, B., & Dvornik, Š. (2006) · Renal Failure · doi:10.1080/08860220600683581 · Cited by 45
The Phosphate Binder Ferric Citrate Alters the Gut Microbiome in Rats with Chronic Kidney Disease
Lau, W. L., Vaziri, N. D., Nunes, A. C. F., Comeau, A., Langille, M. G. I., England, W., Khazaeli, M., Suematsu, Y., Phan, J. L., & Whiteson, K. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.251389 · Cited by 46
Early aging and premature vascular aging in chronic kidney disease
Tanrıöver, C., Çöpür, S., Mutlu, A., Peltek, İ. B., Galassi, A., Ciceri, P., Cozzolino, M. G., & Kanbay, M. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad076 · Cited by 46
Dose-dependent deleterious and salutary actions of the Nrf2 inducer dh404 in chronic kidney disease
Vaziri, N. D., Liu, S., Farzaneh, S. H., Nazertehrani, S., Khazaeli, M., & Zhao, Y. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.022 · Cited by 44
Cardiovascular Problems on Hemodialysis
Ritz, E., & Bommer, J. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01960309 · Cited by 44
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Wang, X., Chaudhry, M. A., Nie, Y., Xie, Z., Shapiro, J. I., & Liu, J. (2017) · Journal of Visualized Experiments · doi:10.3791/55825 · Cited by 44
Koçak, H., Gumuslu, S., Ermiş, C., Mahsereci, E., Sahin, E., Göçmen, A. Y., ERSOY, F. F., Süleymanlar, G., Yakupoğlu, G., & Tuncer, M. A. (2007) · American Journal of Nephrology · doi:10.1159/000109397 · Cited by 44
Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease
Charytan, D. M. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000067 · Cited by 47
Lahera, V., Goicoechea, M., de Vinuesa, S. G., Oubiña, P., Cachofeiro, V., Gómez-Campderá, F. J., Amann, R., & Luño, J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080911 · Cited by 44
PROGRESS IN UREMIC TOXIN RESEARCH: Adiponectin in Patients with Chronic Kidney Disease
Adamczak, M., Chudek, J. T., & Więcek, A. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2009.00587.x · Cited by 43
NFκB in the Development of Endothelial Activation and Damage in Uremia: An In Vitro Approach
Caballo, C., Palomo, M., Cases, A., Galan, A. M., Molina, P., Vera, M., Bosch, X., Escolar, G., & Díaz‐Ricart, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043374 · Cited by 43
Lim, P., Jeng, Y., Wu, M. Y., Pai, M.-A. T., Wu, T.-K., Liu, C.-S., Chen, C. H., Kuo, Y.-C., Chien, S.-W., & Chen, H. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070822 · Cited by 43
Oxidative stress and ferritin levels in haemodialysis patients
Senol, E., Ersoy, A., Erdinc, S., Sarandöl, E., & Yurtkuran, M. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm588 · Cited by 43
Takouli, L., Hadjiyannakos, D., Metaxaki, P., Sideris, V., Filiopoulos, V., Anogiati, A., & Vlassopoulos, D. (2010) · Renal Failure · doi:10.3109/08860221003615795 · Cited by 43
Hogas, S. M., Voroneanu, L. E., Șerban, D. N., Segall, L., Hogas, M. M., Șerban, I. L., & Covic, A. C. (2010) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2010.03.008 · Cited by 43
Penne, E. L., Blankestijn, P. J., Bots, M. L., van den Dorpel, M. A., Grooteman, M. P. C., Nubé, M. J., ter Wee, P. M., & on behalf of the CONTRAST Group (2005) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2005.18107.x · Cited by 43
Sorbents in Acute Renal Failure and End-Stage Renal Disease: Middle Molecule and Cytokine Removal
Winchester, J. F., Silberzweig, J. I., Ronco, C., Kuntsevich, V., Levine, D. M., Parker, T., Kellum, J. A., Salsberg, J. A., Quartararo, P. J., & Levin, N. W. (2004) · Blood Purification · doi:10.1159/000074926 · Cited by 43
Dursun, B. (2010) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s6598 · Cited by 42
Saddadi, F., Alatab, S., Pasha, F., Ganji, M.-R., & Soleymanian, T. (2014) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.124489 · Cited by 42
Molecular mechanisms in cognitive frailty: potential therapeutic targets for oxygen-ozone treatment
Scassellati, C., Ciani, M., Galoforo, A. C., Zanardini, R., Bonvicini, C., & Geroldi, C. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111210 · Cited by 45
Chronic Kidney Disease: A Risk Factor for Cardiovascular Disease
Wali, R. K., & Henrich, W. L. (2005) · Cardiology Clinics · doi:10.1016/j.ccl.2005.03.007 · Cited by 42
Bongartz, L. G., Cramer, M. J., & Braam, B. G. (2004) · Hypertension · doi:10.1161/01.hyp.0000118521.06245.b8 · Cited by 42
Association of plasma manganese levels with chronic renal failure
Sánchez‐González, C., López-Chaves, C., Gómez-Aracena, J., Galindo, P., Aranda, P., & Llopis, J. (2015) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2015.04.001 · Cited by 41
Chen, J., Yang, Y., Lee, W., Liou, C., Lin, T., Chung, Y.-H., Chuang, L., Yang, C., & Chang, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041125 · Cited by 41
A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation
Sosa, M. A., Balk, E. M., Lau, J. S. M., Liangos, O., Balakrishnan, V. S., Madias, N. E., Pereira, B. J. G., & Jaber, B. L. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl376 · Cited by 41
A Randomized Trial of Hemodiafiltration and Change in Cardiovascular Parameters
Mostovaya, I. M., Bots, M. L., van den Dorpel, M. A., Grooteman, M. P. C., Otto Kamp, B., Levesque, R. L., ter Wee, P. M., Nubé, M. J., & Blankestijn, P. J. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07140713 · Cited by 41
Fadaee, S. B., Beetham, K. S., Howden, E. J., Stanton, T., Isbel, N. M., & Coombes, J. S. (2016) · Redox Report · doi:10.1080/13510002.2016.1173326 · Cited by 41
Unexpected Normal Colloid Osmotic Pressure in Clinical States with Low Serum Albumin
Michelis, R., Sela, S., Zeitun, T., Geron, R., & Kristal, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159839 · Cited by 41
Uremia induces adipose tissue inflammation and muscle mitochondrial dysfunction
Cantarin, M. P. M., Whitaker‐Menezes, D., Zhao, L., & Falkner, B. E. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx050 · Cited by 41
Metadata
- Authors
- Himmelfarb, J., Stenvinkel, P., Ikizler, T. A., & Hakim, R. M.
- Affiliations
- Maine Medical Center (US)
- Corresponding author
- Himmelfarb, Jonathan
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 62
- Issue
- 5
- Pages
- 1524-1538
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W1996978408
- Cited by
- 1,179
- References
- 294
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 29 · 2023: 31 · 2022: 36 · 2021: 51 · 2020: 40 · 2019: 30 · 2018: 43 · 2017: 57 · 2016: 49 · 2015: 57 · 2014: 58 · 2013: 71 · 2012: 68
- FWCI
- 10.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Kidney International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- uremia, oxidative stress, cardiovascular disease, atherosclerosis, inflammation, malnutrition, dialysis, uremic solutes, beta2-microglobulin, homocysteine, cysteine, antioxidant therapy, vascular access catheters, cardiovascular mortality
- MeSH terms
- Cardiovascular Diseases, Humans, Uremia, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
